Track Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right )'s current cash ($1.6M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), BLACU shows a current cash of $1.6M. That compares with $1.6M in the prior-year period — down 1.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BLACU's current cash is now $1.6M (was $1.6M) — a 1.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) is outperforming or lagging.
Tracking BLACU's current cash over time shows whether Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.6M That compares with $1.6M in the prior-year period — down 1.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right )'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.6M) with ownership activity and broader fundamentals.